$PWRM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in POWER 3 MEDICAL PRODUCTS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in POWER 3 MEDICAL PRODUCTS INC. Get notifications about new insider transactions in POWER 3 MEDICAL PRODUCTS INC for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 120.00 | 10,000 | 1,200,000 | 44,391,016 | 44.4 M to 44.4 M (-0.02 %) |
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 489.00 | 57,466 | 28,100,874 | 44,401,016 | 44.5 M to 44.4 M (-0.13 %) |
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 211.00 | 24,800 | 5,232,800 | 44,458,482 | 44.5 M to 44.5 M (-0.06 %) |
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 1,001.00 | 117,734 | 117,851,734 | 44,483,282 | 44.6 M to 44.5 M (-0.26 %) |
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 1,800.00 | 200,000 | 360,000,000 | 44,601,016 | 44.8 M to 44.6 M (-0.45 %) |
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 1,700.00 | 200,000 | 340,000,000 | 44,801,016 | 45 M to 44.8 M (-0.44 %) |
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 972.00 | 92,500 | 89,910,000 | 45,001,016 | 45.1 M to 45 M (-0.21 %) |
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 226.00 | 20,000 | 4,520,000 | 45,093,516 | 45.1 M to 45.1 M (-0.04 %) |
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 1,375.00 | 125,000 | 171,875,000 | 45,113,516 | 45.2 M to 45.1 M (-0.28 %) |
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 250.00 | 20,000 | 5,000,000 | 45,238,516 | 45.3 M to 45.2 M (-0.04 %) |
May 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 1,314.00 | 105,000 | 137,970,000 | 45,258,516 | 45.4 M to 45.3 M (-0.23 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 9,203.00 | 438,194 | 4,032,699,382 | 45,363,516 | 45.8 M to 45.4 M (-0.96 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 3,398.00 | 161,806 | 549,816,788 | 45,801,710 | 46 M to 45.8 M (-0.35 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 545.00 | 30,252 | 16,487,340 | 45,963,516 | 46 M to 46 M (-0.07 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 3,267.00 | 180,450 | 589,530,150 | 45,993,768 | 46.2 M to 46 M (-0.39 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 5,237.00 | 289,298 | 1,515,053,626 | 46,174,218 | 46.5 M to 46.2 M (-0.62 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 2,651.00 | 126,200 | 334,556,200 | 46,463,516 | 46.6 M to 46.5 M (-0.27 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 1,550.00 | 73,800 | 114,390,000 | 46,589,716 | 46.7 M to 46.6 M (-0.16 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 4,303.00 | 200,000 | 860,600,000 | 46,663,516 | 46.9 M to 46.7 M (-0.43 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 11,318.00 | 500,000 | 5,659,000,000 | 46,863,516 | 47.4 M to 46.9 M (-1.06 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 2,775.00 | 150,000 | 416,250,000 | 47,363,516 | 47.5 M to 47.4 M (-0.32 %) |
Feb 17 2011 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 9,250.00 | 500,000 | 4,625,000,000 | 47,513,516 | 48 M to 47.5 M (-1.04 %) |
Mar 14 2011 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 230.00 | 12,100 | 2,783,000 | 22,441,737 | 22.5 M to 22.4 M (-0.05 %) |
Mar 14 2011 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 2,128.00 | 112,000 | 238,336,000 | 22,453,837 | 22.6 M to 22.5 M (-0.50 %) |
Mar 14 2011 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 4,130.00 | 216,500 | 894,145,000 | 22,565,837 | 22.8 M to 22.6 M (-0.95 %) |
Mar 14 2011 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 1,920.00 | 96,000 | 184,320,000 | 22,782,337 | 22.9 M to 22.8 M (-0.42 %) |
Mar 14 2011 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 2,690.00 | 134,500 | 361,805,000 | 22,878,337 | 23 M to 22.9 M (-0.58 %) |
Mar 14 2011 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 390.00 | 19,500 | 7,605,000 | 23,012,837 | 23 M to 23 M (-0.08 %) |
Mar 14 2011 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 11,000.00 | 500,000 | 5,500,000,000 | 23,032,337 | 23.5 M to 23 M (-2.12 %) |
Nov 09 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | See Remarks | Sell | S | 11,500.00 | 500,000 | 5,750,000,000 | 48,013,516 | 48.5 M to 48 M (-1.03 %) |
Nov 09 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | See Remarks | Sell | S | 6,900.00 | 300,000 | 2,070,000,000 | 48,513,516 | 48.8 M to 48.5 M (-0.61 %) |
Nov 09 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | See Remarks | Sell | S | 12,680.00 | 550,000 | 6,974,000,000 | 48,813,516 | 49.4 M to 48.8 M (-1.11 %) |
Nov 08 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 3,991.00 | 215,710 | 860,898,610 | 23,532,337 | 23.7 M to 23.5 M (-0.91 %) |
Nov 08 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 7,476.00 | 400,000 | 2,990,400,000 | 23,748,047 | 24.1 M to 23.7 M (-1.66 %) |
Nov 08 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 11,500.00 | 500,000 | 5,750,000,000 | 24,148,047 | 24.6 M to 24.1 M (-2.03 %) |
Nov 08 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 195.00 | 5,000 | 975,000 | 24,648,047 | 24.7 M to 24.6 M (-0.02 %) |
Nov 08 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 917.00 | 23,500 | 21,549,500 | 24,653,047 | 24.7 M to 24.7 M (-0.10 %) |
Nov 08 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 7,754.00 | 198,800 | 1,541,495,200 | 24,676,547 | 24.9 M to 24.7 M (-0.80 %) |
Nov 08 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 6,123.00 | 156,990 | 961,249,770 | 24,875,347 | 25 M to 24.9 M (-0.63 %) |
Nov 08 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 4,397.00 | 118,813 | 522,420,761 | 25,032,337 | 25.2 M to 25 M (-0.47 %) |
Nov 08 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 6,610.00 | 178,625 | 1,180,711,250 | 25,151,150 | 25.3 M to 25.2 M (-0.71 %) |
Nov 08 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Sell | S | 7,495.00 | 202,562 | 1,518,202,190 | 25,329,775 | 25.5 M to 25.3 M (-0.79 %) |
Aug 13 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | See Remarks | Sell | S | 6,650.00 | 207,791 | 1,381,810,150 | 49,363,516 | 49.6 M to 49.4 M (-0.42 %) |
Aug 13 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | See Remarks | Sell | S | 24,581.00 | 768,147 | 18,881,821,407 | 49,571,307 | 50.3 M to 49.6 M (-1.53 %) |
Aug 13 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | See Remarks | Sell | S | 434.00 | 14,000 | 6,076,000 | 50,339,454 | 50.4 M to 50.3 M (-0.03 %) |
May 27 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 32,014.00 | 831,005 | 26,603,794,070 | 50,353,454 | 51.2 M to 50.4 M (-1.62 %) |
May 27 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 6,837.00 | 158,995 | 1,087,048,815 | 51,184,459 | 51.3 M to 51.2 M (-0.31 %) |
May 27 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 26,950.00 | 490,000 | 13,205,500,000 | 51,343,454 | 51.8 M to 51.3 M (-0.95 %) |
May 27 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 16,500.00 | 500,000 | 8,250,000,000 | 51,833,454 | 52.3 M to 51.8 M (-0.96 %) |
Apr 13 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 12,789.00 | 319,701 | 4,088,656,089 | 52,333,454 | 52.7 M to 52.3 M (-0.61 %) |
Apr 13 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 20,936.00 | 523,399 | 10,957,881,464 | 52,653,155 | 53.2 M to 52.7 M (-0.98 %) |
Apr 13 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President and CSO | Sell | S | 6,276.00 | 156,900 | 984,704,400 | 53,176,554 | 53.3 M to 53.2 M (-0.29 %) |
Mar 31 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Grant | A | 0.00 | 15,000,000 | 0 | 25,532,337 | 10.5 M to 25.5 M (+142.42 %) |
Mar 31 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Gift | G | 0.00 | 2,000,000 | 0 | 10,532,337 | 12.5 M to 10.5 M (-15.96 %) |
Mar 31 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Grant | A | 0.00 | 2,960,908 | 0 | 12,532,337 | 9.6 M to 12.5 M (+30.93 %) |
Mar 31 2010 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim CEO and Int ... | Grant | A | 0.00 | 9,571,429 | 0 | 9,571,429 | 0 to 9.6 M |
Mar 17 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Sell | S | 13,172.00 | 239,490 | 3,154,562,280 | 53,333,454 | 53.6 M to 53.3 M (-0.45 %) |
Mar 17 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Sell | S | 1,100.00 | 20,000 | 22,000,000 | 53,572,944 | 53.6 M to 53.6 M (-0.04 %) |
Mar 17 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Sell | S | 102.00 | 1,845 | 188,190 | 53,592,944 | 53.6 M to 53.6 M (0.00 %) |
Mar 11 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Sell | S | 2,590.00 | 46,700 | 120,953,000 | 53,594,789 | 53.6 M to 53.6 M (-0.09 %) |
Mar 11 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Sell | S | 3,011.00 | 54,750 | 164,852,250 | 53,641,489 | 53.7 M to 53.6 M (-0.10 %) |
Mar 11 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Sell | S | 7,547.00 | 137,215 | 1,035,561,605 | 53,696,239 | 53.8 M to 53.7 M (-0.25 %) |
Feb 04 2010 | PWRM | POWER 3 MEDICAL PR ... | GINZLER JOHN P | Option Exercise | A | 0.02 | 10,000,000 | 200,000 | 10,000,000 | ||
Feb 04 2010 | PWRM | POWER 3 MEDICAL PR ... | GINZLER JOHN P | Sell | S | 0.15 | 780,640 | 117,096 | 12,000,000 | 12.8 M to 12 M (-6.11 %) | |
Feb 04 2010 | PWRM | POWER 3 MEDICAL PR ... | GINZLER JOHN P | Grant | A | 0.01 | 780,640 | 10,148 | 12,780,640 | 12 M to 12.8 M (+6.51 %) | |
Feb 04 2010 | PWRM | POWER 3 MEDICAL PR ... | GINZLER JOHN P | Grant | A | 0.02 | 12,000,000 | 240,000 | 12,000,000 | 0 to 12 M | |
Feb 22 2010 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Sell | S | 30,065.00 | 500,000 | 15,032,500,000 | 53,833,454 | 54.3 M to 53.8 M (-0.92 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Option Exercise | C | 0.01 | 27,185 | 190 | 0 | |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Option Exercise | C | 0.03 | 1,097,940 | 32,938 | 27,185 | |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Option Exercise | A | 0.01 | 1,200,000 | 12,000 | 40,481,609 | |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Option Exercise | A | 0.01 | 27,185 | 190 | 1,125,125 | |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Option Exercise | A | 0.04 | 36,598,000 | 1,463,920 | 36,598,000 | |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Option Exercise | A | 0.03 | 1,097,940 | 32,938 | 1,097,940 | |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Grant | A | 0.01 | 7,422,558 | 92,040 | 54,333,454 | 46.9 M to 54.3 M (+15.82 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Sell | S | 0.02 | 471,403 | 9,428 | 46,910,896 | 47.4 M to 46.9 M (-0.99 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Buy | C | 0.01 | 10,312,896 | 72,190 | 47,382,299 | 37.1 M to 47.4 M (+27.82 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Buy | C | 0.03 | 36,598,000 | 1,097,940 | 37,069,403 | 471.4 K to 37.1 M (+7,763.63 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Sell | D | 0.00 | 1,200,000 | 0 | 471,403 | 1.7 M to 471.4 K (-71.80 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Sell | J | 0.00 | 11,703,000 | 0 | 1,671,403 | 13.4 M to 1.7 M (-87.50 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Grant | A | 0.22 | 18,939 | 4,167 | 13,374,403 | 13.4 M to 13.4 M (+0.14 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Grant | A | 0.19 | 21,930 | 4,167 | 13,355,464 | 13.3 M to 13.4 M (+0.16 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Grant | A | 0.10 | 41,867 | 4,187 | 13,333,534 | 13.3 M to 13.3 M (+0.31 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | Goldknopf Ira L | President & CSO | Grant | A | 0.11 | 41,667 | 4,583 | 13,291,667 | 13.3 M to 13.3 M (+0.31 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | GINZLER JOHN P | Chief Financial Off ... | Option Exercise | A | 0.02 | 10,000,000 | 200,000 | 10,000,000 | |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | GINZLER JOHN P | Chief Financial Off ... | Grant | A | 0.01 | 780,640 | 10,148 | 12,780,640 | 12 M to 12.8 M (+6.51 %) |
Oct 21 2009 | PWRM | POWER 3 MEDICAL PR ... | GINZLER JOHN P | Chief Financial Off ... | Grant | A | 0.02 | 12,000,000 | 240,000 | 12,000,000 | 0 to 12 M |
Feb 17 2009 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim Chief Execu ... | Option Exercise | P | 0.04 | 5,000,000 | 200,000 | 5,000,000 | |
Feb 17 2009 | PWRM | POWER 3 MEDICAL PR ... | Park Helen R | Interim Chief Execu ... | Sell | J | 0.00 | 1,500,000 | 0 | 0 | 1.5 M to 0 (-100.00 %) |
Dec 30 2008 | PWRM | POWER 3 MEDICAL PR ... | MCCORMICK MARION JEAN | Chief Accounting Of ... | Option Exercise | D | 0.20 | 10,000 | 2,000 | 0 | |
Dec 30 2008 | PWRM | POWER 3 MEDICAL PR ... | MCCORMICK MARION JEAN | Chief Accounting Of ... | Option Exercise | P | 0.04 | 1,000,000 | 40,000 | 1,000,000 | |
Dec 02 2004 | PWRM | POWER 3 MEDICAL PR ... | ROSINSKI MICHAEL J | CFO | Grant | A | 0.00 | 140,000 | 0 | 140,000 | 0 to 140 K |
Jul 29 2004 | PWRM | POWER 3 MEDICAL PR ... | GRAY R PAUL | Sell | S | 3.00 | 38,141 | 114,423 | 1,000,000 | 1 M to 1000 K (-3.67 %) | |
Jun 30 2004 | PWRM | POWER 3 MEDICAL PR ... | GRAY R PAUL | Sell | S | 2.85 | 500 | 1,425 | 1,038,141 | 1 M to 1 M (-0.05 %) | |
Jun 09 2004 | PWRM | POWER 3 MEDICAL PR ... | NOVAK TIMOTHY S | Sell | S | 216,000.00 | 108,000 | 23,328,000,000 | 1,000,000 | 1.1 M to 1000 K (-9.75 %) | |
Feb 18 2004 | PWRM | POWER 3 MEDICAL PR ... | GRAY ROBERT P | Chief Financial Off ... | Gift | G | 0.25 | 600,000 | 150,000 | 12,738,541 | 13.3 M to 12.7 M (-4.50 %) |
Feb 18 2004 | PWRM | POWER 3 MEDICAL PR ... | NOVAK TIMOTHY S | Chief Executive Off ... | Gift | G | 0.25 | 600,000 | 150,000 | 12,808,849 | 13.4 M to 12.8 M (-4.47 %) |
Page: 1